Skip to main content
. 2020 May 31;2020:3012198. doi: 10.1155/2020/3012198

Figure 6.

Figure 6

Concentration profile of curcumin in plasma versus time after (a) s.i.d. and (b) b.i.d. oral administration of curcumin or Cur-CS nanoparticles. Cur-CS: curcumin-encapsulated chitosan.